<VariationArchive VariationID="2424097" VariationName="NC_000022.10:g.(?_17669209)_(17672720_?)del" VariationType="Deletion" Accession="VCV002424097" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1939254" VariationID="2424097">
      <GeneList>
        <Gene Symbol="ADA2" FullName="adenosine deaminase 2" GeneID="51816" HGNC_ID="HGNC:1839" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q11.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="17178790" stop="17221848" display_start="17178790" display_stop="17221848" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="17660191" stop="17690778" display_start="17660191" display_stop="17690778" Strand="-" />
          </Location>
          <OMIM>607575</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000022.10:g.(?_17669209)_(17672720_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q11.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" innerStart="17669209" innerStop="17672720" display_start="17669209" display_stop="17672720" variantLength="3512" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.(?_17669209)_(17672720_?)del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.(?_17669209)_(17672720_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000022.10:g.(?_17669209)_(17672720_?)del AND Vasculitis due to ADA2 deficiency" Accession="RCV003107329" Version="3">
        <ClassifiedConditionList TraitSetID="13385">
          <ClassifiedCondition DB="MedGen" ID="C3887654">Vasculitis due to ADA2 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24552284</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24552285</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32643137</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13385" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6159" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Vasculitis due to ADA2 deficiency</ElementValue>
                <XRef ID="MONDO:0014306" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyarteritis nodosa, childhoood-onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0007" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VAIHS</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Adenosine deaminase 2 deficiency (DADA2) is a complex systemic autoinflammatory disorder in which vasculopathy/vasculitis, dysregulated immune function, and/or hematologic abnormalities may predominate. Inflammatory features include intermittent fevers, rash (often livedo racemosa/reticularis), and musculoskeletal involvement (myalgia/arthralgia, arthritis, myositis). Vasculitis, which usually begins before age ten years, may manifest as early-onset ischemic (lacunar) and/or hemorrhagic strokes, or as cutaneous or systemic polyarteritis nodosa. Hypertension and hepatosplenomegaly are often found. More severe involvement may lead to progressive central neurologic deficits (dysarthria, ataxia, cranial nerve palsies, cognitive impairment) or to ischemic injury to the kidney, intestine, and/or digits. Dysregulation of immune function can lead to immunodeficiency or autoimmunity of varying severity; lymphadenopathy may be present and some affected individuals have had lymphoproliferative disease. Hematologic disorders may begin early in life or in late adulthood, and can include lymphopenia, neutropenia, pure red cell aplasia, thrombocytopenia, or pancytopenia. Of note, both interfamilial and intrafamilial phenotypic variability (e.g., in age of onset, frequency and severity of manifestations) can be observed; also, individuals with biallelic ADA2 pathogenic variants may remain asymptomatic until adulthood or may never develop clinical manifestations of DADA2.</Attribute>
                <XRef ID="NBK544951" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12383" />
                <XRef ID="12383" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31393689</ID>
                <ID Source="BookShelf">NBK544951</ID>
              </Citation>
              <XRef ID="404553" DB="Orphanet" />
              <XRef ID="C3887654" DB="MedGen" />
              <XRef ID="MONDO:0014306" DB="MONDO" />
              <XRef Type="MIM" ID="615688" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7072932" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_001282225.1_22_Deletion (exons 5-7)|MedGen:C3887654" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003793507" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24552284</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24552285</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32643137</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 5-7 of the ADA2 gene. This deletion is out-of-frame, and is expected to create a premature termination codon and result in an absent or disrupted protein product. Loss-of-function variants in ADA2 are known to be pathogenic (PMID: 24552284, 24552285). A similar copy number variant has been observed in individual(s) with clinical features of adenosine deaminase 2 deficiency (DADA2) (PMID: 32643137). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.(?_17669209)_(17672720_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3887654" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7072932" TraitType="Disease" MappingType="XRef" MappingValue="C3887654" MappingRef="MedGen">
        <MedGen CUI="C3887654" Name="Vasculitis due to ADA2 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

